Delrand Closes Private Placement
Sep 19, 2016 12:31 pm UTC| Business
TORONTO, Sept. 19, 2016 -- Delrand Resources Limited (the “Company”) (NEX:DRN.H) (JSE:DRN) announces that, further to its September 2, 2016 press release, it has closed a non-brokered private placement of 600,000 common...
UPS On-Demand 3D Printing Network Expanded To Asia
Sep 19, 2016 12:30 pm UTC| Business
ATLANTA, Sept. 19, 2016 -- Singapore to serve as newest location for Fast Radius 3D printing factory Dedicated UPS team to help customers integrate 3D printing manufacturing and distribution solutions into...
Sep 19, 2016 12:30 pm UTC| Business
CHARLOTTESVILLE, Va., Sept. 19, 2016 -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therapeutics for cancer and other...
Martha Stewart to Keynote Alibaba’s First Ever Tmall Super Kitchen Event
Sep 19, 2016 12:30 pm UTC| Business
NEW YORK, Sept. 19, 2016 -- Sequential Brands Group, Inc. (Nasdaq:SQBG) and Alibaba Group Inc. (NYSE:BABA) announced today that Martha Stewart will headline Alibaba’s inaugural Tmall Super Kitchen event on September 20,...
Cellectar Biosciences to Present at Ladenburg Thalmann 2016 Healthcare Conference
Sep 19, 2016 12:30 pm UTC| Business
MADISON, Wis., Sept. 19, 2016 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused biotechnology company, today announces that Jim Caruso, president and CEO of Cellectar, will present at the...
Hemispherx Biopharma Regains Compliance with NYSE MKT Continued Listing Standards
Sep 19, 2016 12:30 pm UTC| Business
PHILADELPHIA, Sept. 19, 2016 -- Hemispherx Biopharma (NYSE MKT:HEB) (the “Company”), announced today that, based on a notice received on September 15, 2016 from the New York Stock Exchange, Inc., the Company has...
Sep 19, 2016 12:30 pm UTC| Business
BURLINGAME, Calif., Sept. 19, 2016 -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies, today...